Search details
1.
Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies.
Mol Cancer
; 16(1): 116, 2017 07 06.
Article
in English
| MEDLINE | ID: mdl-28683746
2.
CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers.
Int J Cancer
; 141(5): 967-976, 2017 09 01.
Article
in English
| MEDLINE | ID: mdl-28542846
3.
Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas.
Mol Cancer
; 10: 85, 2011 Jul 21.
Article
in English
| MEDLINE | ID: mdl-21777459
4.
Colorectal carcinomas with microsatellite instability display a different pattern of target gene mutations according to large bowel site of origin.
BMC Cancer
; 10: 587, 2010 Oct 27.
Article
in English
| MEDLINE | ID: mdl-20979647
5.
Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours.
J Pathol
; 217(5): 693-701, 2009 Apr.
Article
in English
| MEDLINE | ID: mdl-19142971
6.
Gene expression profiles of CMS2-epithelial/canonical colorectal cancers are largely driven by DNA copy number gains.
Oncogene
; 38(33): 6109-6122, 2019 08.
Article
in English
| MEDLINE | ID: mdl-31308487
7.
Exploratory analyses of consensus molecular subtype-dependent associations of TP53 mutations with immunomodulation and prognosis in colorectal cancer.
ESMO Open
; 4(3): e000523, 2019.
Article
in English
| MEDLINE | ID: mdl-31321083
8.
Transcriptional and functional consequences of TP53 splice mutations in colorectal cancer.
Oncogenesis
; 8(6): 35, 2019 May 15.
Article
in English
| MEDLINE | ID: mdl-31092812
9.
Truncated PPM1D impairs stem cell response to genotoxic stress and promotes growth of APC-deficient tumors in the mouse colon.
Cell Death Dis
; 10(11): 818, 2019 10 28.
Article
in English
| MEDLINE | ID: mdl-31659152
10.
Novel mutations of the suppressor gene PTEN in colorectal carcinomas stratified by microsatellite instability- and TP53 mutation- status.
Hum Mutat
; 29(11): E252-62, 2008 Nov.
Article
in English
| MEDLINE | ID: mdl-18781614
11.
Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies.
Clin Cancer Res
; 24(4): 794-806, 2018 02 15.
Article
in English
| MEDLINE | ID: mdl-29242316
12.
Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors.
Mol Oncol
; 11(9): 1156-1171, 2017 09.
Article
in English
| MEDLINE | ID: mdl-28556483
13.
Multilevel genomics of colorectal cancers with microsatellite instability-clinical impact of JAK1 mutations and consensus molecular subtype 1.
Genome Med
; 9(1): 46, 2017 05 24.
Article
in English
| MEDLINE | ID: mdl-28539123
14.
Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study.
Lancet Gastroenterol Hepatol
; 1(3): 207-216, 2016 11.
Article
in English
| MEDLINE | ID: mdl-28404093
15.
Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis.
Neuro Oncol
; 17(1): 63-9, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-25038505
16.
NEDD4 is overexpressed in colorectal cancer and promotes colonic cell growth independently of the PI3K/PTEN/AKT pathway.
Cell Signal
; 25(1): 12-8, 2013 Jan.
Article
in English
| MEDLINE | ID: mdl-22974840
17.
A tissue-based comparative effectiveness analysis of biomarkers for early detection of colorectal tumors.
Clin Transl Gastroenterol
; 3: e27, 2012 Dec 06.
Article
in English
| MEDLINE | ID: mdl-23324654
18.
MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer.
Neoplasia
; 14(9): 868-79, 2012 Sep.
Article
in English
| MEDLINE | ID: mdl-23019418
19.
Phospholipase C isozymes are deregulated in colorectal cancer--insights gained from gene set enrichment analysis of the transcriptome.
PLoS One
; 6(9): e24419, 2011.
Article
in English
| MEDLINE | ID: mdl-21909432
20.
Three epigenetic biomarkers, GDF15, TMEFF2, and VIM, accurately predict bladder cancer from DNA-based analyses of urine samples.
Clin Cancer Res
; 16(23): 5842-51, 2010 Dec 01.
Article
in English
| MEDLINE | ID: mdl-20975101